Startseite UR
Einträge von Buser, Lorenz auf dem Publikationsserver
 | Eine Stufe nach oben |
Anzahl der Einträge: 3.
2023
Meyer, Stefanie, Buser, Lorenz 
, Haferkamp, Sebastian, Berneburg, Mark, Maisch, Tim, Klinkhammer-Schalke, Monika, Pauer, Armin, Vogt, Thomas und Garbe, Claus
(2023)
Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I–IIA cutaneous melanoma.
European Journal of Cancer 182, S. 77-86.
Volltext nicht vorhanden.
, Haferkamp, Sebastian, Berneburg, Mark, Maisch, Tim, Klinkhammer-Schalke, Monika, Pauer, Armin, Vogt, Thomas und Garbe, Claus
(2023)
Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I–IIA cutaneous melanoma.
European Journal of Cancer 182, S. 77-86.
Volltext nicht vorhanden.
2019
Hutterer, Georg C., Posch, Florian, Buser, Lorenz , Zigeuner, Richard, Morshäuser, Laura, Otto, Wolfgang, Wild, Peter J., Burger, Maximilian, May, Matthias, Pichler, Martin und Brookman-May, Sabine D.
(2019)
BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation study.
Urologic Oncology: Seminars and Original Investigations 37 (7), S. 510-518.
Volltext nicht vorhanden.
, Zigeuner, Richard, Morshäuser, Laura, Otto, Wolfgang, Wild, Peter J., Burger, Maximilian, May, Matthias, Pichler, Martin und Brookman-May, Sabine D.
(2019)
BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation study.
Urologic Oncology: Seminars and Original Investigations 37 (7), S. 510-518.
Volltext nicht vorhanden.
2018
Morshaeuser, Laura, May, Matthias, Burger, Maximilian, Otto, Wolfgang, Hutterer, Georg C., Pichler, Martin, Klatte, Tobias, Wild, Peter, Buser, Lorenz und Brookman-May, Sabine
(2018)
p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models.
Urologic Oncology: Seminars and Original Investigations 36 (3), 94.e15-94.e21.
Volltext nicht vorhanden.
Universitätsbibliothek
Publikationsserver
Kontakt:
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707